In melanoma, Li et al. have shown that gain of Skp2 protein expression are implicated in melanoma progression and Skp2 cytoplasmic expression predicted worse 10-year overall survival in primary melanoma, suggesting that cytoplasmic expression of Skp2 defines a subset of aggressive melanomas [13]. Here, SKP2 is linked to melanoma.